{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:18:04Z","timestamp":1792459084961,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1136\/ard.2009.109389","type":"journal-article","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T00:13:11Z","timestamp":1246579991000},"page":"1036-1043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":377,"title":["Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis"],"prefix":"10.1016","volume":"69","author":[{"given":"Mark A","family":"Little","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nightingale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C A","family":"Verburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"De Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2009.109389_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1681\/ASN.V7123","article-title":"Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis","volume":"7","author":"Hogan","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/ard.2009.109389_bib2","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2009.109389_bib3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-113-9-656","article-title":"Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network","volume":"113","author":"Falk","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2009.109389_bib4","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1046\/j.1523-1755.2002.00605.x","article-title":"Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients","volume":"62","author":"Hauer","year":"2002","journal-title":"Kidney Int"},{"key":"10.1136\/ard.2009.109389_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1523-1755.2002.00089.x","article-title":"Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups","volume":"61","author":"Hauer","year":"2002","journal-title":"Kidney Int"},{"key":"10.1136\/ard.2009.109389_bib6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<349::AID-PATH524>3.0.CO;2-A","article-title":"Pathogenesis of ANCA-associated systemic vasculitis","volume":"190","author":"Harper","year":"2000","journal-title":"J Pathol"},{"key":"10.1136\/ard.2009.109389_bib7","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/ard.2007.071936","article-title":"Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force","volume":"67","author":"Mukhtyar","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.109389_bib8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","article-title":"Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study","volume":"41","author":"Booth","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1136\/ard.2009.109389_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2009.109389_bib10","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.109389_bib11","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/ard.2009.109389_bib12","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2009.109389_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2009.109389_bib14","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V95842","article-title":"Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement","volume":"9","author":"Westman","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/ard.2009.109389_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.109389_bib16","first-page":"161","article-title":"Classical versus non-renal Wegener's granulomatosis","volume":"87","author":"Luqmani","year":"1994","journal-title":"Q J Med"},{"key":"10.1136\/ard.2009.109389_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780400222","article-title":"Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides","volume":"40","author":"Exley","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.109389_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2009.109389_bib19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/rheumatology\/keh522","article-title":"ANCA-associated renal vasculitis at the end of the twentieth century\u2014a disease of older patients","volume":"44","author":"Harper","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.109389_bib20","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1046\/j.1523-1755.2002.00279.x","article-title":"Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency","volume":"61","author":"Haubitz","year":"2002","journal-title":"Kidney Int"},{"key":"10.1136\/ard.2009.109389_bib21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2165\/00003088-197904050-00004","article-title":"Clinical pharmacokinetics of cyclophosphamide","volume":"4","author":"Grochow","year":"1979","journal-title":"Clin Pharmacokinet"},{"key":"10.1136\/ard.2009.109389_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/blood.V86.2.457.bloodjournal862457","article-title":"A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (>55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)","volume":"86","author":"Rowe","year":"1995","journal-title":"Blood"},{"key":"10.1136\/ard.2009.109389_bib23","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1182\/blood.V88.10.3675.bloodjournal88103675","article-title":"Hematopoietic growth factors as adjuncts to the treatment of acute myeloid leukemia","volume":"88","author":"Schiffer","year":"1996","journal-title":"Blood"},{"key":"10.1136\/ard.2009.109389_bib24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2165\/00003088-199120030-00002","article-title":"Clinical pharmacokinetics of cyclophosphamide","volume":"20","author":"Moore","year":"1991","journal-title":"Clin Pharmacokinet"},{"key":"10.1136\/ard.2009.109389_bib25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00254741","article-title":"The disposition of cyclophosphamide in a group of myeloma patients","volume":"3","author":"Bramwell","year":"1979","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1136\/ard.2009.109389_bib26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.109389_bib27","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/1529-0131(200008)43:8<1841::AID-ANR21>3.0.CO;2-Q","article-title":"Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegner's granulomatosis undergoing immunosuppressive therapy","volume":"43","author":"Chung","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.109389_bib28","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/ndt\/gfm640","article-title":"Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitis","volume":"23","author":"Stassen","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/ard.2009.109389_bib29","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/1529-0131(199908)42:8<1752::AID-ANR26>3.0.CO;2-6","article-title":"Granulocyte colony-stimulating factor treatment for cyclophosphamide-induced severe neutropenia in Wegener's granulomatosis","volume":"42","author":"Hellmich","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.109389_bib30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/rheumatology\/ken035","article-title":"Venous thromboembolism in ANCA-associated vasculitis\u2014incidence and risk factors","volume":"47","author":"Stassen","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.109389_bib31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-142-8-200505030-00011","article-title":"Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study","volume":"142","author":"Merkel","year":"2005","journal-title":"Ann Intern Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724194599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724194599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2009.109389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:12:15Z","timestamp":1737249135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724194599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0003496724194599"],"URL":"https:\/\/doi.org\/10.1136\/ard.2009.109389","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2009.109389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}